JCR Pharmaceuticals to Present at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) 2025
– Data to be showcased in one oral presentation and four poster presentations – HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd.... Read more.
Xpanner Officially Launches X1 Kit, the First Scalable Physical AI-based Automation Solution for Construction Sites
SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–#AaaS—Xpanner, a leader in construction automation solutions, today unveiled its flagship X1 Kit, the... Read more.
Blackline Safety Announces Fiscal Third Quarter 2025 Financial Results Conference Call
CALGARY, Canada–(BUSINESS WIRE)–Blackline Safety Corp. (TSX: BLN), a global leader in connected safety technology, today announced it will release its... Read more.
Metropolitan Commercial Bank Named Official SBA Loan Provider
NEW YORK–(BUSINESS WIRE)–#mcb–Metropolitan Commercial Bank (the “Bank,” “MCB”), a full-service commercial bank headquartered in New York... Read more.
IonQ Appoints Former EMC Vice Chairman Bill Teuber to Board of Directors
Teuber brings large-scale enterprise expertise to help drive IonQ’s next phase of growth COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the leader... Read more.
IonQ Highlighted in 12 Events and 4 Scientific Papers at 2025 IEEE International Conference on Quantum Computing and Engineering
IonQ’s scientific leadership in quantum computing highlighted by scientific papers accepted for peer-review and company’s participation in 12 onsite events COLLEGE... Read more.
IonQ Appoints Former Ariba & Cloudera CFO Jim Frankola to Board of Directors
Frankola brings cloud and high-performance computing expertise to support IonQ’s continued commercial momentum in the era of broad quantum advantage COLLEGE PARK,... Read more.
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the European Medicines Agency (EMA) has granted... Read more.
Accelerant Announces Second Quarter 2025 Results
ATLANTA–(BUSINESS WIRE)–Accelerant Holdings (“Accelerant”) (NYSE: ARX), a leading technology company operating a data-driven risk exchange platform... Read more.
Best Buy Reports Second Quarter Results
Comparable Sales Increased 1.6% Diluted EPS of $0.87 Adjusted Diluted EPS of $1.28 Reiterates FY26 Adjusted Diluted EPS Guidance of $6.15 to $6.30 MINNEAPOLIS–(BUSINESS... Read more.